Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Domestic Recombinant Human Follitropin for WHO Class II Anovulation
NCT02335879Phase 3Completed
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- May 2008
- Primary completion
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of follitropin alfa in anovulation, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started May 2008; status: completed.
02
Drugs
follitropin alfa
03
Conditions
anovulation
Beyond the preview
Go deeper on NCT02335879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02335879.